Brief: Kronos Bio To Present Preclinical Data for KB-0742 in Poster Presentation at AACR-NCI-EORTC 2021
30/09/2021 21:48
Sept 30 (Reuters) - Kronos Bio Inc KRON.O :
* KRONOS BIO TO PRESENT PRECLINICAL DATA FOR KB-0742, AN
ORAL CDK9
INHIBITOR TARGETING MYC-AMPLIFIED CANCERS, IN POSTER
PRESENTATION AT AACR-NCI-EORTC 2021
Source text for Eikon: ID:nGNX83N0SB
Further company coverage: KRON.O
Recent news on Kronos Bio
See all newsBrief: Kronos Bio Inc - Terminates Office Lease At 301 Binney Street - SEC Filing
Brief: Kronos Bio Inc - Enters Transition Agreement With Genentech
U.S. STOCKS ON THE MOVE - Ambarella, Dell, Nordstrom
U.S. STOCKS ON THE MOVE - Golden Ocean, Guess, Symbotic
U.S. STOCKS ON THE MOVE-HP, Urban Outfitters, 3D Systems